Applied Therapeutics, Inc. (NASDAQ:APLT – Get Rating) was the target of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 350,200 shares, a decrease of 21.0% from the March 31st total of 443,300 shares. Based on an average trading volume of 317,200 shares, the […]
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Rating) saw a large decrease in short interest in April. As of April 15th, there was short interest totalling 350,200 shares, a decrease of 21.0% from the March 31st total of 443,300 shares. Based on an average daily trading volume, of 317,200 shares, the days-to-cover ratio is presently 1.1 […]
Applied Therapeutics (NASDAQ:APLT – Get Rating) had its price target lowered by stock analysts at Robert W. Baird from $18.00 to $14.00 in a note issued to investors on Tuesday, The Fly reports. Separately, Citigroup reduced their price objective on Applied Therapeutics from $23.00 to $5.00 and set a “buy” rating on the stock in […]
Applied Therapeutics (NASDAQ:APLT – Get Rating) had its price objective trimmed by Citigroup from $23.00 to $5.00 in a research note released on Wednesday morning, The Fly reports. The firm currently has a buy rating on the stock. Applied Therapeutics Price Performance Applied Therapeutics stock opened at $0.81 on Wednesday. Applied Therapeutics has a 12 […]
Applied Therapeutics (NASDAQ:APLT – Get Rating) had its target price decreased by Citigroup from $23.00 to $5.00 in a report published on Wednesday, The Fly reports. Citigroup currently has a buy rating on the stock. Applied Therapeutics Trading Up 1.3 % Shares of NASDAQ:APLT opened at $0.81 on Wednesday. The stock’s 50-day moving average price […]